Science, Computers & Technology Civil Remedies Health

Pharmaceutical Industry False Claims Act (FCA) Healthcare Prescription Drugs FDA PHI Preliminary Injunctions Data Breach Qui Tam DOJ Settlement Biosimilars HIPAA Medical Devices Medicare Whistleblowers BPCIA HHS Medicaid Hospitals Amgen Data Protection Generic Drugs Appeals Class Action OCR Patents Physicians Sandoz v Amgen Affordable Care Act Anti-Kickback Statute Damages Pharmaceutical Patents Pharmacies Popular Amarin Compliance First Amendment Fraud Health Care Providers Kickbacks Off-Label Promotion Omnicare Patent Infringement Patent Litigation Relators Actavis Inc. Antitrust Litigation Electronic Medical Records FDCA First-to-File Free Speech Health Information Technologies HONI Marketing Nursing Homes OIG Personally Identifiable Information Sandoz SCOTUS Sealed Records Stark Law State Medical Board Telemedicine Advertising Anti-Competitive Attorney Generals Biologics Civil Monetary Penalty Class Certification Clinical Laboratories CMIA Commercial Marketing Competition Covered Entities Cybersecurity FDA Approval FTC Government Investigations Health Insurance In-Person Exam Inter Partes Review Proceedings Jurisdiction Life Sciences Medical Records Medicare Part D Medtronic Misbranding Mobile Devices Monopolization Negligence Off-Label Use Orphan Drugs Patient Confidentiality Breaches PHRMA Public Disclosure Punitive Damages Section 340B Settlement Agreements Sherman Act Standing Summary Judgment AbbVie Abuse of Power Acquisitions Administrative Authority Administrative Remedies America Invents Act ANDA Anthem Blue Cross Anticompetitive Agreements Antitrust Injuries Antitrust Investigations Antitrust Violations Apotex App Developers Avandia Boston Scientific Breach of Contract Bristol-Myers Squibb Calculation of Damages China Chiropractors CIGNA CMS Commercial Speech Concentra Consent Order Corrective Actions Counterclaims Criminal Prosecution Cyber Attacks Data Theft Debt Collection Declaratory Judgments Department of Health and Human Services Destruction of Evidence Disclosure Disgorgement Dismissals Dispute Resolution Drug & Alcohol Abuse Drug Approvals Duty to Warn Elder Abuse Eli Lilly Enablement Inquiries Encryption Enforcement Actions Estoppel False Billing False Statements FCRA Federal Contractors FERA FFDCA Final Rules Financial Conduct Authority (FCA) Fines First Impression France Frivolous Lawsuits FTC Act Genentech GlaxoSmithKline Hackers Halifax Hospital Halliburton Hart-Scott-Rodino Act Hatch-Waxman Health Insurance Exchanges Healthcare Fraud HIPAA Audits HIPAA Breach HIPAA Omnibus Rule HITECH HRSA Humana Identity Theft Indictments Infectious Diseases Innovator Liability Invasion of Privacy Irreparable Harm Janssen Pharmaceuticals Labeling Learned Intermediary MACs Managed Care Contracts Media Medical Foods Medicare Advantage MedQuest Mental Health Merck Neglect Negligent Misrepresentation New Legislation NIH Notice Provisions Opioid Orange Book Overpayment OxyContin Patent Dance Patent Invalidity Patent Prosecution Patent Trial and Appeal Board Penalties Permanent Injunctions Personal Liability Personalized Medicine Physician Medicare Reimbursements Post-Grant Review Precision Medicine Initiative (PMI) Preemption Prescribing Authority Pretext Prior Art Proctor & Gamble Product Exclusivity Product Hopping Professional Liability Proposed Legislation QCA Healthplan Radiopharmaceuticals Rebates Refill Reminders Remuneration Reporting Requirements Retaliation Rulemaking Process SEC Section 5 Securities Litigation Self-Referral Sexual Harassment Shareholder Litigation Standard of Care Stem cells STRONG Patents Act Supervision Sutter Health Telehealth Theft Transvaginal Mesh TRICARE Unfair Competition Universal Health Services Inc v United States ex rel Escobar USPTO Vaccinations Wells Fargo Whistleblower Awards Wrongful Death WSLA